文献速递牙周病

牙周非手术治疗对临界糖尿病胰岛素抵抗与敏感性的影响:随机对照试验

Effect of non-surgical periodontal therapy on insulin resistance and insulin sensitivity among individuals with borderline diabetes: A randomized controlled trial.
PubMed 文献 · J Dent · 2019-04-12

结果显示组间血糖和胰岛素无显著差异,但干预前探诊出血(BOP)较低组在BMI、HOMA-IR、HOMA-β和Matsuda指数上有显著改善。

要点

  • 牙周非手术治疗对临界糖尿病患者的血糖和胰岛素代谢指标无显著整体影响
  • 干预前BOP较低者治疗后BMI、HOMA-IR、HOMA-β和Matsuda指数显著改善
  • 基线BOP与BMI变化呈正相关趋势(P=0.06),BMI变化与HbA1c、HOMA-IR、HOMA-β正相关

核心结论

  • 牙周非手术治疗对临界糖尿病患者的胰岛素和糖代谢标志物无显著影响。
  • 干预前BOP较低(<37%)的参与者治疗后BMI、空腹血清胰岛素、HOMA-IR、HOMA-β和Matsuda指数有显著改善。

研究设计与样本

  • 交叉随机对照试验,纳入经75g口服葡萄糖耐量试验诊断的临界糖尿病未用药参与者。
  • 早期干预组前6个月接受洁治和根面平整,随后6个月不干预;后期干预组顺序相反。

主要发现

  • 干预期和非干预期组间血糖和胰岛素浓度无显著差异。
  • 按干预前BOP中位数分组分析,低BOP组BMI、HOMA-IR、HOMA-β和Matsuda指数变化显著改善(P<0.05)。
  • 基线BOP与BMI变化呈正相关(P=0.06)。
  • BMI变化与HbA1c、HOMA-IR和HOMA-β变化正相关(P<0.05),与Matsuda指数变化负相关(P=0.001)。

关键数值与推荐

  • 临界糖尿病诊断依据75g口服葡萄糖耐量试验。
  • 低BOP组定义为干预前BOP<37%。
  • 主要结局包括空腹或负荷后血清葡萄糖和胰岛素、BMI、HOMA-IR、HOMA-β和Matsuda指数。

临床怎么用

  • 对临界糖尿病患者进行牙周非手术治疗时,整体糖代谢获益不显著。
  • 干预前BOP较低(<37%)的患者可能从牙周非手术治疗中获得BMI和胰岛素抵抗指标的改善。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To investigate the effect of non-surgical periodontal therapy on insulin resistance and sensitivity among individuals with borderline diabetes not receiving medications. METHODS: A crossover, randomized controlled trial was conducted among participants with borderline diabetes diagnosed by a 75-g oral glucose tolerance test. Participants were randomly assigned to either an early or later intervention group. The early intervention group underwent non-surgical periodontal therapy of scaling and root planing during the first 6 months, followed by a 6-month non-intervention period. The order was reversed in the later intervention group. Primary outcomes included: fasting or post-load serum glucose and insulin, body mass index (BMI), HOMA-IR, HOMA-β, and Matsuda Index. RESULTS: Seventy-four participants were randomized, and 71 participants completed the trial. There were no significant differences between groups in glucose and insulin concentrations during the intervention and non-intervention periods. When analyzed within groups by median-split of bleeding on probing (BOP) levels before intervention, the lower BOP group showed improved changes in BMI, HOMA-IR, HOMA-β, and Matsuda Index (P < 0.05). Further, we observed a positive correlation between baseline BOP and change in BMI (P = 0.06). Change in BMI was positively correlated with changes in HbA1c, HOMA-IR, and HOMA-β (P < 0.05), and inversely correlated with change in Matsuda Index (P = 0.001). CONCLUSIONS: Periodontal therapy had no significant effect on markers related to insulin and glucose metabolism among individuals with borderline diabetes. However, participants with a lower BOP (%) showed significant improvements in BMI, fasting serum insulin, HOMA-IR, HOMA-β and Matsuda Index. CLINICAL SIGNIFICANCE: Among individuals diagnosed with borderline diabetes, those who had <37% of a lower BOP (%) showed potential improvements in BMI, fasting serum insulin, HOMA-IR, HOMA-β and Matsuda Index following non-surgical periodontal therapy.

来源:J Dent,查看原文。版权归原作者所有。

引用

  1. Nishioka S, Maruyama K, Tanigawa T, et al. Effect of non-surgical periodontal therapy on insulin resistance and insulin sensitivity among individuals with borderline diabetes: A randomized controlled trial. J Dent. 2019. PMID: 30986513. doi:10.1016/j.jdent.2019.04.005

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。